Literature DB >> 28616851

Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life.

Motahare Mokhtarzade1, Rouholah Ranjbar2, Nastaran Majdinasab3, Darpan Patel4, Mehdieh Molanouri Shamsi5.   

Abstract

PURPOSE: Multiple sclerosis is associated with immune system dysfunction and chronic inflammation; however, possible relations between immunologic and metabolic factors and some psychological indexes such as fatigue and quality of life, especially in relation to exercise training, have not yet been investigated. The present study was designed to investigate the effect of aerobic interval training on interleukin-10/tumor necrosis factor ratio and adipokine (leptin and adiponectin) concentrations in women with multiple sclerosis. Furthermore, the relationship between these factors with fatigue and quality of life were assessed.
METHODS: Forty women with multiple sclerosis (Expanded Disability Status Scale ≤3) were randomized into either a non-exercising control or training group. The training group performed 8-weeks of upper and lower limb aerobic interval training. Serum concentrations of tumor necrosis factorα, interleukin-10, leptin, and adiponectin were measured before and after the 8-week intervention. Moreover, antropometric measures and measures for fatigue and quality of life were determined at the onset of and after exercise training.
RESULTS: The results revealed that leptin and tumor necrosis factorα levels significantly decreased subsequent to the aerobic interval training. Although blood adiponectin levels considerably increased in the training group, interleukin-10 and interleukin-10/tumor necrosis factorα ratio underwent no substantial change after the exercise training. In addition, the aerobic interval training was associated with improvement in fatigue, quality of life, and maximal oxygen consumption.
CONCLUSIONS: Our findings suggested that aerobic interval training can be an effective strategy for managing the immune system at least by its significant impact on inflammatory cytokines and adipokines levels in women with multiple sclerosis. Additionally, this positive impact improved fatigue and adipose tissue indicators.

Entities:  

Keywords:  Adipokines; Cytokines; Fatigue; Inflammation; Multiple sclerosis

Mesh:

Substances:

Year:  2017        PMID: 28616851     DOI: 10.1007/s12020-017-1337-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  50 in total

1.  Acute and chronic cytokine responses to resistance exercise and training in people with multiple sclerosis.

Authors:  T Kjølhede; U Dalgas; A B Gade; M Bjerre; E Stenager; T Petersen; K Vissing
Journal:  Scand J Med Sci Sports       Date:  2015-06-23       Impact factor: 4.221

2.  Body composition from fluid spaces and density: analysis of methods. 1961.

Authors:  W E Siri
Journal:  Nutrition       Date:  1993 Sep-Oct       Impact factor: 4.008

3.  Determination of maximal aerobic power during upper-body exercise.

Authors:  M N Sawka; M E Foley; N A Pimental; M M Toner; K B Pandolf
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-01

4.  Objectively quantified physical activity in persons with multiple sclerosis.

Authors:  Rachel E Klaren; Robert W Motl; Deirdre Dlugonski; Brian M Sandroff; Lara A Pilutti
Journal:  Arch Phys Med Rehabil       Date:  2013-07-29       Impact factor: 3.966

Review 5.  The role of leptin/adiponectin ratio in metabolic syndrome and diabetes.

Authors:  Patricio López-Jaramillo; Diego Gómez-Arbeláez; Jose López-López; Cristina López-López; Javier Martínez-Ortega; Andrea Gómez-Rodríguez; Stefany Triana-Cubillos
Journal:  Horm Mol Biol Clin Investig       Date:  2014-04

6.  Cytokine mRNA expression in patients with multiple sclerosis and fatigue.

Authors:  Peter Flachenecker; Irene Bihler; F Weber; M Gottschalk; Klaus V Toyka; Peter Rieckmann
Journal:  Mult Scler       Date:  2004-04       Impact factor: 6.312

7.  Validity and reliability of the Persian version of the multiple sclerosis quality of life questionnaire.

Authors:  H Ghaem; A Borhani Haghighi; P Jafari; A R Nikseresht
Journal:  Neurol India       Date:  2007 Oct-Dec       Impact factor: 2.117

8.  Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women.

Authors:  Miyao Matsubara; Shoji Maruoka; Shinji Katayose
Journal:  Eur J Endocrinol       Date:  2002-08       Impact factor: 6.664

9.  The relation between peptide hormones and sex hormone in patients with multiple sclerosis.

Authors:  Elham Eftekhari; Masoud Etemadifar; Ali Ebrahimi; Shahrzad Baradaran
Journal:  Iran J Neurol       Date:  2013

Review 10.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

View more
  18 in total

Review 1.  Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration.

Authors:  Zohara Sternberg
Journal:  Neuromolecular Med       Date:  2018-02-10       Impact factor: 3.843

2.  Cytokine Profile in Patients with Multiple Sclerosis Following Exercise: A Systematic Review of Randomized Clinical Trials.

Authors:  Parisa Najafi; Maryam Hadizadeh; Jadeera Phaik Geok Cheong; Hamidreza Mohafez; Suhailah Abdullah
Journal:  Int J Environ Res Public Health       Date:  2022-07-02       Impact factor: 4.614

3.  Effects of High-Intensity Interval Training on Selected Adipokines and Cardiometabolic Risk Markers in Normal-Weight and Overweight/Obese Young Males-A Pre-Post Test Trial.

Authors:  Nejmeddine Ouerghi; Mohamed Kacem Ben Fradj; Martine Duclos; Anissa Bouassida; Moncef Feki; Katja Weiss; Beat Knechtle
Journal:  Biology (Basel)       Date:  2022-06-02

Review 4.  Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Authors:  Paolo Riccio; Rocco Rossano
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

5.  Serum Histidine is Lower in Fatigued Women with Multiple Sclerosis.

Authors:  Bryan D Loy; Brett W Fling; Kylie M Sage; Rebecca I Spain; Fay B Horak
Journal:  Fatigue       Date:  2019-05-07

Review 6.  Is there a link between inflammation and fatigue in multiple sclerosis?

Authors:  Moussa A Chalah; Samar S Ayache
Journal:  J Inflamm Res       Date:  2018-06-07

7.  Salivary IL-1ß as an Objective Measure for Fatigue in Multiple Sclerosis?

Authors:  Katrin Hanken; Carina Sander; Lara Qaiser; Hans-Peter Schlake; Andreas Kastrup; Michael Haupts; Paul Eling; Helmut Hildebrandt
Journal:  Front Neurol       Date:  2018-07-16       Impact factor: 4.003

8.  Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS - study protocol of a randomized controlled trial.

Authors:  Niklas Joisten; Annette Rademacher; Wilhelm Bloch; Alexander Schenk; Max Oberste; Ulrik Dalgas; Dawn Langdon; Daniel Caminada; Mette-Triin Purde; Roman Gonzenbach; Jan Kool; Philipp Zimmer; Jens Bansi
Journal:  BMC Neurol       Date:  2019-03-08       Impact factor: 2.474

9.  Association of plasma leptin, pro-inflammatory adipokines and cancer-related fatigue in early-stage breast cancer patients: A prospective cohort study.

Authors:  Yi Long Toh; Chia Jie Tan; Angie Hui Ling Yeo; Maung Shwe; Han Kiat Ho; Yan Xiang Gan; Koon Mian Foo; Pat Chu; Karin Olson; Alexandre Chan
Journal:  J Cell Mol Med       Date:  2019-04-23       Impact factor: 5.310

10.  Exercise intensity-dependent immunomodulatory effects on encephalomyelitis.

Authors:  Nina Fainstein; Reuven Tyk; Olga Touloumi; Roza Lagoudaki; Yehuda Goldberg; Oryan Agranyoni; Shiri Navon-Venezia; Abram Katz; Nikolaos Grigoriadis; Tamir Ben-Hur; Ofira Einstein
Journal:  Ann Clin Transl Neurol       Date:  2019-08-01       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.